Back
Medpace Holdings Quote, Financials, Valuation and Earnings
![](/images/offers/ims/large/offer4.jpg)
$1,300 into $45,000 in just 4 MONTHS?!
See here to see the full details.
Buy
51
MEDP
Medpace Holdings
Last Price:
380.36
Seasonality Move:
6.55%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer2.jpg)
Free presentation on how to trade options for overnight gains
Get the free overnight options training here.Medpace Holdings Price Quote
$380.36
-0.48 (-0.13%)
(Updated: July 26, 2024 at 6:50 PM ET)
Medpace Holdings Key Stats
Buy
51
Medpace Holdings (MEDP)
is a Buy
Day range:
$369.52 - $388.11
52-week range:
$227.21 - $459.77
Dividend yield:
0%
P/E ratio:
42.89
P/S ratio:
5.99
P/B ratio:
15.46%
Volume:
493K
Avg. volume:
284.3K
1-year change:
48.42%
Market cap:
$11.8B
Revenue:
$1.9B
EPS:
$10.63
How Much Does Medpace Holdings Make?
-
How Much Are Medpace Holdings's Sales Annually?
MEDP Revenues are $1.9B -
How Much Profit Does Medpace Holdings's Make A Year?
MEDP net income is $282.8M
Is Medpace Holdings Growing As A Company?
-
What Is Medpace Holdings's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.15% -
What Is Medpace Holdings's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0.42%
Medpace Holdings Stock Price Performance
-
Did Medpace Holdings Stock Go Up Last Month?
Medpace Holdings share price went down by -6.54% last month -
Did MEDP's Share Price Rise Over The Last Year?
MEDP share price rose by 48.42% over the past 1 year
What Is Medpace Holdings 52-Week High & Low?
-
What Is Medpace Holdings’s 52-Week High Share Price?
Medpace Holdings has traded as high as $459.77 over the past 52 weeks -
What Is Medpace Holdings’s 52-Week Low Share Price?
Medpace Holdings has traded as low as $227.21 over the past 52 weeks
Medpace Holdings Price To Free Cash Flow
-
Is Medpace Holdings Stock Overvalued?
Medpace Holdings is trading at a price to free cash flow ratio of 24.18 -
Is Medpace Holdings Stock Undervalued?
Medpace Holdings EV to Free Cash Flow ratio is 22.47 -
What Is Medpace Holdings’s Price Earnings Growth Ratio?
MEDP PEG ratio is 1.33 -
Is Medpace Holdings Trading At A Premium To Earnings?
Medpace Holdings EV to EBIT ratio is 29.57
Is It Risky To Buy Medpace Holdings?
-
How Much Debt Does Medpace Holdings Have?
Total long term debt quarterly is $0 -
How Much Cash Does Medpace Holdings Have?
Cash and short term investments quarterly total is $510.9M -
What Is Medpace Holdings’s Book Value Per Share?
Book value per share is 24.63
Is Medpace Holdings Cash Flow Positive?
-
What Is MEDP Cash Flow From Operations?
Cash flow from operations (TTM) is $539.9M -
What Is Medpace Holdings’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$39.4M -
What Is Medpace Holdings’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$26.9M
Medpace Holdings Return On Invested Capital
-
Is Management Doing A Good Job?
MEDP return on invested capital is 58.36% -
What Is Medpace Holdings Return On Assets?
ROA measures how assets are converting to revenues and is 20.55% -
What Is MEDP Return On Equity?
ROE is a measure of profitability and is 59.49%
Medpace Holdings Earnings Date & Stock Price
-
What Is Medpace Holdings's Stock Price Today?
A single share of MEDP can be purchased today for 380.84 -
What Is Medpace Holdings’s Stock Symbol?
Medpace Holdings trades on the nasdaq under the ticker symbol: MEDP -
When Is Medpace Holdings’s Next Earnings Date?
The next quarterly earnings date for Medpace Holdings is scheduled on October 23, 2024 -
When Is MEDP's next ex-dividend date?
Medpace Holdings's next ex-dividend date is July 27, 2024 -
How To Buy Medpace Holdings Stock?
You can buy Medpace Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Medpace Holdings Competitors
-
Who Are Medpace Holdings's Competitors?
Below is a list of companies who compete with Medpace Holdings or are related in some way:
Medpace Holdings Dividend Yield
Data Unavailable
Medpace Holdings Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 42.49% | 5.24% |
Revenue: | 14.59% | -0.07% |
Analyst Recommendations
Buy Recommendations: | 7 |
---|---|
Hold Recommendations: | 2 |
Sell Recommendations: | 0 |
Price Target: | 416.92 |
Upside from Last Price: | 9.47% |